2020-12-23,Is the Options Market Predicting a Spike in Relmada (RLMD) Stock?
2020-12-09,Is RLMD A Good Stock To Buy Now?
2020-12-07,Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
2020-12-03,We Think Relmada Therapeutics (NASDAQ:RLMD) Can Afford To Drive Business Growth
2020-11-17,Relmada Therapeutics to Participate in Upcoming Investor Conferences
2020-10-27,"Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones"
2020-10-23,New Strong Sell Stocks for October 23rd
2020-09-15,Top Pharmaceutical Stocks for Q4 2020
2020-08-31,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"
2020-08-27,"Do Insiders Own Lots Of Shares In Relmada Therapeutics, Inc. (NASDAQ:RLMD)?"
2020-07-17,Oppenheimer: These 2 Strong Buy Stocks Are Poised to Surge by Over 80%
2020-07-13,Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select MarketÂ®
2020-07-07,Is It Too Late to Buy These 3 Pharmaceutical Stocks?
2020-06-26,We're Not Worried About Relmada Therapeutics's (NASDAQ:RLMD) Cash Burn
2020-06-24,"Hedge Funds Are Nibbling On Relmada Therapeutics, Inc. (RLMD)"
2020-06-23,Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms
2020-06-23,Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms
2020-06-09,Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-29,Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
2020-05-27,Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
2020-05-26,Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
2020-05-21,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors"
2020-05-19,Could Opioids Treat Depression? This Biotech Plans to Find Out
2020-04-28,"Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs"
2020-04-27,Goldman Sachs: 2 Stocks That Could Climb Over 60%
2020-03-31,"Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety"
2020-03-28,"Should You Take Comfort From Insider Transactions At Relmada Therapeutics, Inc. (NASDAQ:RLMD)?"
2020-03-24,"Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development"
2020-03-09,"Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development"
2020-02-25,Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference
2020-02-06,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Relmada Therapeutics, Inc.- RLMD"
2020-01-10,Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer
2020-01-02,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"
2019-12-20,"Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool"
2019-12-10,"Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock"
2019-12-09,"Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares"
2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission"
2019-12-04,"The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug"
2019-12-03,Relmada Therapeutics Announces Pricing of Public Offering of Common Stock
2019-12-03,Relmada Therapeutics Announces Proposed Public Offering of Common Stock
2019-11-19,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"
2019-11-13,"What Kind Of Shareholder Appears On The Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) Shareholder Register?"
2019-10-17,"Relmada to Ring NASDAQ Stock Market Opening Bell on Friday, October 18"
2019-10-15,Relmada Therapeutics stock rockets 137% on positive trial of depression treatment
2019-10-15,Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial
2019-10-15,Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression
